Skip to main content
. 2018 Jun 24;8(14):3949–3963. doi: 10.7150/thno.26161

Figure 1.

Figure 1

(A) Schematic illustration of the assembly of oligo- or polylactide-tethered SN38 prodrugs with clinically approved amphiphilic copolymers (e.g., PEG-PLA) to form stable nanoparticles. (B) Chemical structure and synthetic scheme of oLAn-SN38 conjugate 1 (n = 8) or PLAn-SN38 conjugates 2-4 (n = 17, 36, and 71, respectively). SN38 was tethered to the carboxyl-terminated oLA or PLA through a hydrolytic ester bond linkage.